Ahmed Mabroor, Beyreuther Elke, Gantz Sebastian, Horst Felix, Meyer Juergen, Pawelke Jörg, Schmid Thomas E, Stolz Jessica, Wilkens Jan J, Bartzsch Stefan
Institute of Radiation Medicine (IRM), Helmholtz Zentrum München GmbH, German Research Center for Environmental Health, Neuherberg, Germany.
Department of Radiation Oncology, TUM School of Medicine and Health, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Front Oncol. 2024 Dec 17;14:1473625. doi: 10.3389/fonc.2024.1473625. eCollection 2024.
Proton Minibeam Radiation Therapy has shown to widen the therapeutic window compared to conventional radiation treatment in pre-clinical studies. The underlying biological mechanisms, however, require more research.
The purpose of this study was to develop and characterize a mechanical collimation setup capable of producing 250µm wide proton minibeams with a center-to-center distance of 1000µm.
To find the optimal arrangement Monte Carlo simulations were employed using the Geant4 toolkit TOPAS to maximize key parameters such as the peak-to-valley dose ratio (PVDR) and the valley dose rate. The experimental characterization of the optimized setup was carried out with film dosimetry at the University Proton Therapy beamline in Dresden and the proton beamline of the University of Washington Medical Center in Seattle with 150MeV and 50.5MeV, respectively. A microDiamond detector (PTW, Freiburg, Germany) was utilized at both beamlines for online proton minibeam dosimetry.
A PVDR of 10 was achieved in Dresden and a PVDR of 14 in Seattle. Dosimetry measurements were carried out with EBT3 films at a depth of 5mm in a polymethylmethacrylate (PMMA) phantom. When comparing film dosimetry with the microDiamond, excellent agreement was observed in the valleys. However, the peak dose showed a discrepancy of approximately 10% in the 150MeV beam and 20% in the 50.5MeV beam between film and microDiamond.
The characteristics of the minibeams generated with our system compares well with those of other collimated minibeams despite being smaller. The deviations of microDiamond measurements from film readings might be subject to the diamond detector responding differently in the peak and valley regions. Applying previously reported correction factors aligns the dose profile measured by the microDiamond with the profile acquired with EBT3 films in Dresden.
The novel proton minibeam system can be operated independently of specific beamlines. It can be transported easily and hence used for inter-institutional comparative studies. The quality of the minibeams allows us to perform and experiments in the future. The microDiamond was demonstrated to have great potential for online dosimetry for proton minibeams, yet requires more research to explain the observed discrepancies.
在临床前研究中,质子微束放射疗法已显示出与传统放射治疗相比能拓宽治疗窗口。然而,其潜在的生物学机制仍需更多研究。
本研究的目的是开发并表征一种机械准直装置,该装置能够产生中心距为1000µm、宽度为250µm的质子微束。
为找到最佳配置,使用Geant4工具包TOPAS进行蒙特卡罗模拟,以最大化诸如峰谷剂量比(PVDR)和谷剂量率等关键参数。在德累斯顿大学质子治疗束线以及西雅图华盛顿大学医学中心的质子束线分别以150MeV和50.5MeV对优化后的装置进行实验表征,使用薄膜剂量测定法。在两条束线上均使用微型金刚石探测器(PTW,德国弗莱堡)进行在线质子微束剂量测定。
在德累斯顿实现了PVDR为10,在西雅图实现了PVDR为14。在聚甲基丙烯酸甲酯(PMMA)模体中5mm深度处使用EBT3薄膜进行剂量测定。将薄膜剂量测定法与微型金刚石探测器进行比较时,在谷区观察到了极好的一致性。然而,在150MeV束中,薄膜与微型金刚石探测器之间的峰值剂量存在约10%的差异,在50.5MeV束中存在20%的差异。
尽管我们系统产生的微束尺寸更小,但其特性与其他准直微束的特性相比仍很出色。微型金刚石探测器测量值与薄膜读数之间的偏差可能是由于金刚石探测器在峰区和谷区的响应不同。应用先前报道的校正因子可使微型金刚石探测器测量的剂量分布与在德累斯顿用EBT3薄膜获得的剂量分布一致。
新型质子微束系统可独立于特定束线运行。它易于运输,因此可用于机构间的比较研究。微束的质量使我们能够在未来开展相关实验。微型金刚石探测器已被证明在质子微束在线剂量测定方面具有巨大潜力,但仍需要更多研究来解释观察到的差异。